Serum transgelin is a novel prognostic biomarker for COVID-19 patients
BackgroundTransgelin is a central actin-binding protein of the calponin family and involved in the process of multiple pulmonary diseases. Nevertheless, the role of transgelin in Coronavirus disease 2019 (COVID-19) patients is confusing.MethodsAll 317 COVID-19 patients were recruited from two hospit...
Saved in:
| Main Authors: | Lei Gao, Ying Liu, Qi-Yuan He, Yu Wang, Ya-Lin Jiang, Jin Yang, Lin Fu, Hui Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1423182/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrodin reduces myocardial ischemia/reperfusion injury via transgelin2/CNPase-mediated apoptosis regulation
by: Changyan Li, et al.
Published: (2025-07-01) -
Recombinant expression and functional analysis of transgelin-like protein from the shell of Mytilus coruscus
by: JIANG Yuting, et al.
Published: (2020-10-01) -
Associations of serum MANF with severity and prognosis in community-acquired pneumonia patients
by: Wen-Nan Wang, et al.
Published: (2025-04-01) -
Serum syndecan-1 is related to severity and prognosis of COVID-19 patients: a perspective cohort study
by: Mengmeng Ma, et al.
Published: (2025-07-01) -
Relationship between serum Midkine and Omentin-1 levels and the severity of sepsis in patients and their prognostic value
by: Lin Gao, et al.
Published: (2024-12-01)